Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
He’s waiting on $3 to $5 dollars per share. Could take a year and a half.
I think I will sell the remaining shares if these is no news soon
I own elite so not sure what any one means by a case for not owning it.
Looking to enter...watching closely....Like the vibe here..
The Oxy situation is fascinating because we get to watch it play out but it's a national news item too. I'm still trying to figure out how you can have a case on a patent that has been since ruled invalid. Something has to give.
An agreement with Purdue would give us the jump and what if we are approved but Accord was first to file. How would that work? It's interesting. PDUFA date is upon us
Thanks I am. Been selling and made a ton of money. Just holding some of what I used to own. Did I make as much as I could have - no. Did make a lot. Yes. Playing with house money now
Lot of shares bought in 2015 at 42 cents.
Will we ever hit 800 M - that would be great
I can recall you demanding a sale of the company for 15 cents. It’s more than double that now. You must be absolutely thrilled. I am.
11/5/15. Stock price was 42 cents.
Just saying
I really think that anyone wanted to acquire elite has enough data to make an offer. Nasrat should take an offer and retire. He’s been at this for 13 years. Time to head to sunny fl with carter and enjoy life.
The “future” looks bright. CEO will do well just with his share of MIKAH alone
He’s been CEO for almost 14 years.
Anyone seriously following the stock, or who actually own shares, knows and understands the working timeline. It's quite exciting, and many of the catalysts are much sooner than "coming months". However yes, the coming months DO hold a lot of exciting events. Much of that information is posted here regularly - however it IS in English, so that can cause confusion for foreign/offshore entities. In fact, some of those fools claim to have sold all their shares at .15 cents!!! LOL - not only did they miss out on significant gains, but they likely had trouble reestablishing a position. LOL, so sad! All we can do is laugh at those people who did not (or refuse to) understand how positive Elite's position currently is.
Hey Eltp emperor. Thanks for the tip.
If it is not this Monday then next !!!
Remain strong!!!
Hey Eltp emperor thank you for buying more
Agree!!!! When our CEO cashes out, I will be right next to him at the cashier's window!!!
Nasrat is honest and as a ceo he provides great information
Trading is for patient people. It takes time to be rich.
800% roi in 1+ year not too shabby.
1500-2000% more coming.
$10 billion combined IMS markets for all there drugs.
$5 billion ANDA will be approved in just weeks.
It’s About To Get REAL!!!!!!
For the new eyes visiting this board:
Seeking Alpha Transcript from August 15/2024 Conference Call in its entirety:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174928441
Amended transcript by NASDAQ2020 to include additional highlighted info; re: IQVIA values
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175100328
6-8 was is not very long when you actually own shares in the co.
Next week looks promising
8 year old article ??
Who can explain what the MIKAH tax means. I’d really like to understand what impact, if any , there is to the PPS. Thanks
Question. Why is eveything with Elite in the coming months ? Eveything is always later. Soon. We will keep you updated.
Very interesting read thanks for the info. We’ll see how it plays out in the coming months.
I agree there is a lot of great news so why isn’t elite worth more? Is it because of MIKAh
some lite reading for a Sunday
https://www.fiercepharma.com/sales-and-marketing/purdue-loses-a-battle-war-against-oxycontin-generics#:~:text=It%27s%20bad%20news%20for%20Purdue%20Pharma%20but%20good,to%20cheap%20knockoff%20versions%20of%20the%20blockbuster%20med.
Another spin on the Purdue patent loss
It's bad news for Purdue Pharma but good news for generics makers such as Teva Pharmaceutical Industries ($TEVA). A federal appeals court affirmed a lower court's decision to toss out some Purdue patents for its top-selling pain drug OxyContin, further opening the door to cheap knockoff versions of the blockbuster med.
I think part of elites issue is that Nasrat says things that in my opinion take too long to materialize.
How much $$ we talkin’
Cake for a better I-hub experience put all non shareholders on ignore. Easy to tell who is who.
GLTY
Fidelity is having fraud issues...it's been well discussed on reddit. It's causing some accounts to have long settling periods. But not all.
I’m fidelity, just had a trade/sell and checked a new box to have the funds directly trf to my other bank. Happened within the 3 day period?
YES
&
YES !!!!!!!!!!!!
Flick The Tick ...................
Repeal The Mikah tax !!!!!!!!!!!!!
IB_🤴🏻
That's My Opinion
We should focus on MIKAH and what this means to a potential buyout. Does Nasrat get paid twice
That’s crazy. I figured there would be a T+2 settlement wait period, but that’s like 2 weeks.
I had a problem with them. I wrote a letter to their ceo, their support, finra and the sec.
This is not normal practice
Only thing confusing is your post. Why are you so focused on this today? Are you worried that the short position you are working to cover is in trouble. Seems that way.
I love talking about Mikah. It's only one product and it's the blood flowing through Elites R&D veins right now.
I’m sure that Nasrat , oh wait, I mean Elite, could not buy out Sungen. Lucky that Elite, oh no wait, I mean Nasrat,had the money to buy out sungen. Wonder if there a legal reason that seeing that Nasrat had the money, he couldn’t just loan the money to Nasat, oh no wait, I mean Elite.
It’s so confusing
Excellent questions. I wonder if MIKAH makes all of this messy. Just not sure
Here is the question on Oxy I have been thinking about. Elite was sued over patent infringement by Purdue. This was expected obviously as Purdue is trying to hold on by their fingernails at this point and that battle is about over as the verdicts and appeal verdicts come in....
So, if Elite is being sued for patent infringement and that patent and associated patents have been ruled invalid (see the verdict released last week in the Accord trial),
Isn't the trial case basically over? There is a stay Pending that outcome (which has been completed in Elite's favor) so what is next?
Can really only be three things
1- Elite and Purdue make a deal and they have this stay based on the outcome which was ruled in Elites favor. So Purdues best chance to get something out of this to make a deal and license it to Elite for some predetermined period of time
2- Elite files motion to dismiss since there is no grounds as patent is invalid. Pdufa date is in a few weeks and Elite already did all the extra studies that were needed.
3-Purdue tries another angle but I'm not sure what else there is. The patent invalidated seems to be the entire piece. It's the hard shell aspect of the pill and is found to be "obvious". The rest is just Oxycontin generic...
I think all of us shareholders should demand that Nasrat provide more transparency around MIKAH.
What drugs are pending launch? One is due here pretty soon. Couple weeks. Can you tell us what the CEO noted about these drug launches. How many weeks are they spaced out?
Can you tell us what they are?
Bet you aren't allowed. Lol
Yes. Elite would benefit greatly from the CEO following up on his public commitments / comments
I wonder why MIKAH still continues to be a concern for investors. Why doesn’t Elite just consolidate and eliminate this concern. Seems wrong that MIKAH swooped in here and bought cheap ( I think). Did elite have insight into what a great investment this would be ? Just my opinion
FIDELITY TRADING, CANT BELIEVE AFTER SETTLEMENT FIDELITY IS NOT ALLOWING YOU TO WITHDRAW CASH BUT THE WILL LET YOU BUY MORE STOCK,I SOLD STOCK SHARES ON SEPTEMBER 17 AND WONT BE ALLOWED TO WITHDRAW CASH UNTIL OCTOBER 3, FIDELITY BROKERAGE ANYONE HAVING THE SAME BS
Followers
|
1002
|
Posters
|
|
Posts (Today)
|
37
|
Posts (Total)
|
409459
|
Created
|
03/24/09
|
Type
|
Free
|
Moderators jimr1717 mrwrn2010 NASDAQ2020 IB_ namtae Dr JoeBarducci |
Senior Moderator: IB_
Posted: 7/02/2024
________________________________________________________________________________________________________________
Elite Pharmaceuticals, Inc. |
Website | Location | Employees | Facility | CEO |
www.elitepharma.com | Northvale, New Jersey | 64 | 85,000 sq ft | Nasrat Hakim |
Products & Pipeline | ||||
Drug | Market Size | Status | Competitors | Marketed By |
Adderall IR | 389.8 M | On Market | 15 | Elite |
Adderall XR | 1.56 B | On Market | 10 | Elite & Prasco |
Dantrolene | 6.3 M | On Market | 2 | Elite |
Isradipine | 5.5 M | On Market | 1 | Elite |
Loxapine | 5 M | On Market | 2 | Elite |
Phendimetrazine | 4.5 M | On Market | 4 | Elite |
Trimipramine | 2 M | On Market | 1 | Elite |
Naltrexone | 16 M | On Market | 5 | Precision Dose |
Phentermine Capsules | 7.5 M | On Market | 6 | Precision Dose |
Phentermine Tablets | 40 M | On Market | 8 | Precision Dose |
Vigabatrin | 233.7 M | On Market | 13 | Pyros |
Doxycycline | 85 M | Approved (Discontinued) | 9 | ---------- |
Tylenol with Codeine | 45 M | Approved in Launch Queue | 5 | ---------- |
Dopamine Agonist | 12 M | Filed with FDA - 22 Dec 2022 | ---------- | ---------- |
Methotrexate | 63.4M | On Market | 8 | Elite |
Percocet | 500 M | Approved in Launch Queue | 14 | ---------- |
Norco | 477 M | Approved in Launch Queue | 12 | ---------- |
Methadone | 30 M | Approved in Launch Queue | 8 | ---------- |
OxyContin | 720 M | Filed with FDA - 17 Aug 2023 | ??? | ---------- |
Vyvanse | 5.10 B | Filed with FDA - 21 Dec 2023 | 11 | ---------- |
Concerta | 1.16 B | In Development (Final Stages) | 8 | ---------- |
Financials | ||||
Fiscal Year | Revenue | Change | Net Income | Change |
2019 | 7,568,508 | ---------- | (9,279,321) | ---------- |
2020 | 17,994,639 | +137.76% | (2,240,351) | +75.86% |
2021 | 25,380,749 | +41.05% | 5,088,421 | +327.13% |
2022 | 32,262,117 | +27.11% | 8,898,245 | +74.87% |
2023 | 34,155,114 | +5.87% | 3,561,846 | -59.97% |
2024 | 56,625,128 | +65.79% | 20,108,631 | +464.56% |
2025 Q-1 | 18,803,063 | +109.39% | 3,864,056 | +144.00% |
2025 Q-2 | ||||
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |